Sun City, ARIZONA1 Active Studies

Wet Age-Related Macular Degeneration Clinical Trials in Sun City, ARIZONA

Find 1 actively recruiting wet age-related macular degeneration clinical trials in Sun City, ARIZONA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
630
Enrolling

Recruiting Wet Age-Related Macular Degeneration Studies in Sun City

About Wet Age-Related Macular Degeneration Clinical Trials in Sun City

Wet age-related macular degeneration is the advanced form of AMD where abnormal blood vessels grow under the retina and leak fluid or blood. It can cause rapid vision loss if untreated. Treatment involves regular anti-VEGF injections that can stabilize or improve vision.

There are currently 1 wet age-related macular degeneration clinical trials recruiting participants in Sun City, ARIZONA. These studies are seeking a combined 630 participants. Research is being sponsored by AbbVie. Clinical trial participation is free and participants receive study-related medical care at no cost.

Wet Age-Related Macular Degeneration Clinical Trials in Sun City — FAQ

Are there wet age-related macular degeneration clinical trials in Sun City?

Yes, there are 1 wet age-related macular degeneration clinical trials currently recruiting in Sun City, ARIZONA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Sun City?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Sun City research site will contact you about next steps.

Are clinical trials in Sun City free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Sun City studies also compensate for your time and travel.

What wet age-related macular degeneration treatments are being tested?

The 1 active trials in Sun City are testing new therapies including novel drugs, biologics, and treatment approaches for wet age-related macular degeneration.

Data updated March 2, 2026 from ClinicalTrials.gov